对于中风患者认知功能障碍的数字干预:系统性审查和元分析
1School of Rehabilitation Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Journal of medical Internet research
|July 24, 2025
概括
数字疗法有效地改善了中风后的认知功能. 计算机辅助认知疗法 (CACT) 在执行功能方面表现出色,而机器人辅助疗法 (RAT) 对于基本认知是最好的,尽管存在研究局限性.
科学领域:
- 神经科学是一个神经科学.
- 康复医学 康复医学 康复医学
- 数字健康数字健康
背景情况:
- 数字技术为中风后的认知改善提供了潜力.
- 数字干预的有效性和最佳治疗策略仍然不清楚.
- 关于脑卒中后认知障碍的数字治疗现有证据是矛盾的.
研究的目的:
- 评估各种数字干预措施在中风后改善认知功能的有效性.
- 为有关数字治疗的临床决策提供基于证据的建议.
- 综合当前关于虚拟现实,计算机辅助认知疗法和机器人辅助治疗中风后认知障碍的研究.
主要方法:
- 在多个数据库 (PubMed,科学网等) 中进行系统搜索. 在2025年1月之前.
- 包括对患有中风后认知障碍的成年人进行数字干预 (VR,CACT,RAT) 的随机对照试验 (RCT).
- 使用R软件进行网络元分析,根据MoCA和MMSE得分对干预疗效进行比较,评估异质性和证据质量.
主要成果:
- 分析了27个涉及2128篇文章的RCT.
- 计算机辅助认知疗法 (CACT) 在蒙特利尔认知评估 (MoCA) 评分 (MD=3.03) 中显示出明显的优势.
- 机器人辅助疗法 (RAT) 在迷你精神状态检查 (MMSE) 评分 (MD=5.99) 中表现出最高的疗效,而VR和CCT在MMSE上没有显著改善.
结论:
- 数字疗法对于中风后的认知增强是有效的.
- CACT和RAT显示了特定领域的疗效 (执行功能与基本认知).
- 由于研究异质性,偏差风险和有限的样本大小,建议谨慎行事;建议进行进一步研究.
更多相关视频
08:53Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
590
07:42Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
Published on: December 16, 2022
3.1K
相关概念视频
Cognitive Development During Adulthood
250
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
250
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
206
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
206
